Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.
FI: 6,493
Type: Article
Collaboration
Year: 2018
Writers
Moreso, F; Crespo, M; Ruiz, JC; Torres, A; Gutierrez-Dalmau, A; Osuna, A; Perello, M; Pascual, J; Towers, I.B.; Redondo-Pachon, D; Rodrigo, E; Lopez-Hoyos, M; Seron, D.
Magazine
Title: AMERICAN JOURNAL OF TRANSPLANTATION
Quartile
- D1